URO. THE GLOBAL PROSTATE CANCER MEETING Hot Spots in Prostate Cancer MADRID SEPTEMBER Hospital Universitario Puerta de Hierro Majadahonda

Transcription

1 15-16 SEPTEMBER THE GLOBAL PROSTATE CANCER MEETING Hot Spots in Prostate Cancer SEPTEMBER. HOTEL NH EBUILDING Organizers: Hospital Universitario Puerta de Hierro Majadahonda Department or Urology

2 TWO FULL DAYS, INCLUDING LIVE SURGERIES DEMOSTRATIONS, WORKSHOP IN MRI INTERPRETATION WITH CLINICAL CASES, ROUND TABLES, PANES DISCUSSIONS, STATE OF THE ART LECTURES AND GREAT INTERACTION WITH THE AUDIENCE COURSE DIRECTORS: Dr. Hashim Ahmed Dra. Claire Allen Dr. Fernando Bianco Prof. Joaquín Carballido Dr. Jonathan Coleman Dr. Mark Emberton Dr. Juan Ignacio Martínez-Salamanca Dr. John P. Mulhall Dr. Jasprey Sandhu The Global Prostate Cancer Meeting will be organized in 4 AREAS OF KNOWLEGDE: 01 DIAGNOSIS & MANAGEMENT OF CLINICALLY LOCALIZED PROSTATE CANCER. WHERE ARE WE GOING? mpmri of the Prostate, Update on reporting mpmri findings, Fusion guided biopsy, active surveillance, focal therapy, radical surgery and others LOCALLY ADVANCED & M0/M1 HORMONOSENSITIVE (HS) AND HORMORE- SISTANT (HR) PROSTATE CANCER: QUO VADIS? High risk PC management, Failure after radical & focal therapy, New development & long-term outcomes in Hormonotherapy, Chemotherapy in real life and Inmunotherapy awakening and other strategies. SEXUAL DYSFUNTION AFTER RADICAL PELVIC SURGERY: FROM BASIC SCIENCE TO CLINICAL PRACTICE. Incidence & Prevalence Challenging cases-operative technique. 04 MALE URINARY INCONTINENCE AFTER PROSTATE CANCER TREATMENTS.

3 THURSDAY, 15 SEPTEMBER DIAGNOSIS & MANAGEMENT OF CLINICALLY LOCALIZED PROSTATE CANCER. WHERE ARE WE GOING? mp MRI of the Prostate, Update on reporting mpmri findings, Fusion guided biopsy, active surveillance, focal therapy, radical surgery and others. LECTURES Overdiagnosis, overtreatment and re-treatment: What exactly means in? How to interprete biology of localized PC: Clinical implications, heterogenicity, genomics and others. MRI as a screening tools for PC: Fusion or Confusion. PIRAD 2.0: How to report and how to draw clinical traslation. Prostate biopsy: To whom and how: Fusion, No-fusion (cognitive), standard. Active Surveillance: Long-term outcome and follow-up criteria. Focal Therapy: State of the Art (HIFU, CRIO, NanoKnife, etc). Radical Treatment: Oncological & functional outcomes after 30 years perspective. Role of hormonal neoadyuvant regimens: Time to rethinking? LIVE DEMOSTRATIONS Fusion guided biopsy: MIM Symphony, Biopsee, Hitachi, BK Medical, Artemis, UroNav. Focal Therapy: Focal HIFU, Focal Cryo and Nanoknife. 01 LOCALLY ADVANCED & M0/M1 HORMONOSENSITIVE (HS) AND HORMORESISTANT (HR) PROSTATE CANCER: QUO VADIS? High risk PC management, Failure after radical & focal therapy, New development & long-term outcomes in Hormonotherapy, Chemotherapy in real life and Inmunotherapy awakening and other strategies. LECTURES Oligometastatic disease definition & role of radical surgery. Outcomes of multimodal strategies in High Risk PC. 02

4 THE GLOBAL PROSTATE CANCER MEETING Hot Spots in Prostate Cancer Role of PET-CT in disease evaluation & follow-up. Salvage lymphadenectomy: Indications & outcomes. Failure after radical therapy: Adyuvant or Salvage Radiotherapy, hormones, Whole gland Cryo or HIFU, Radical Prostatectomy. Failure after focal therapy: radical prostatectomy, external beam radiotherapy, other options. What means hormonal resistance to androgen blockade?: An holistic visión. Current indications for chemotherapy in advanced prostate cancer and in real life clinical practice. Long-term results of esteroidogenesis manipulation in CRPC. Androgen receptor as theraupetic target in CRPC. Implications of bone metabolism in CRPC. Development and current status of new therapeutic options in CRPC (Inmunotherapy, PRAP, PI3K Pathway, AKY, MTOR, HDAC..) FRIDAY, 16 SEPTEMBER SEXUAL DYSFUNTION AFTER RADICAL PELVIC SURGERY: FROM BASIC SCIENCE TO CLINICAL PRACTICE. Incidence & Prevalence Challenging cases-operative technique MALE URINARY INCONTINENCE AFTER PROSTATE CANCER TREATMENTS. LECTURES Re-operative Prosthetic Surgery. Re-operative Prosthetic Surgery for Sphincter Weakness Incontinence. Re-operative Prosthetic Surgery for Erectile Dysfunction

5 Madrid september Is there a New Paradigm for the Cause and Management of Incontinence Following Radical Prostatectomy. Male Urinary Incontinence - Management Options and Complications of the Artificial Urinary Sphincter. Penile Prosthesis Update: New Techniques of Component Placement in Scarred Surgical Planes. Penile Prosthesis & Peyronie s Disease Update. New Strategies to increase patient satisfaction after IPP: Meeting patient s expectations. Genital Prosthetic Surgery Market: USA & Europe, Why are so different? LIVE DEMOSTRATIONS Penoscrotal penile implant technique Infrapubic penile implant technique Simultaneus Double Implant (IPP + AUS). IPP plus Graft/Modeling/Incision Priapism (IPP Implantation). Glanspexy. Revisions Male Sling & AUS. VIDEOS Mini-invasive and no-touch techniques Grafting procedure Prosthetic Urology Management of Complications DEBATES & CLINICAL CASES The faculty will present difficult cases for discussion. The attendees may also bring clinical cases and controversies they would like to be discussed.

6 THE GLOBAL PROSTATE CANCER MEETING Hot Spots in Prostate Cancer DATE: VENUE: ORGANIZERS: SEPTEMBER HOTEL NH EBUILDING Padre Damián Madrid. Puerta de Hierro-Majadahonda University Hospital Department or Urology Autonomous University of Madrid Faculty of Medicine. Department of Surgery Memorial Sloan-Kettering Cancer Center. New York, USA. University College London Hospital - UCL. London, UK. REGISTRATION FEE: RESIDENTS*: Registration fee includes: Documentation, admission to scientific events, coffee break and lunch. Technical Secretariat: Gran Vía, 81. 5º Dpto Bilbao T. (0034) F info@congresosxxi.com -